 Brain Neoplasms
"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Descriptor ID |
D001932
|
| MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
| Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Primary Brain Neoplasms
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 0 | 2 | | 1993 | 0 | 1 | 1 | | 1994 | 0 | 2 | 2 | | 1995 | 2 | 1 | 3 | | 1998 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 0 | 3 | | 2001 | 1 | 0 | 1 | | 2002 | 3 | 0 | 3 | | 2003 | 5 | 4 | 9 | | 2004 | 5 | 2 | 7 | | 2005 | 7 | 0 | 7 | | 2006 | 7 | 1 | 8 | | 2007 | 14 | 0 | 14 | | 2008 | 5 | 2 | 7 | | 2009 | 6 | 0 | 6 | | 2010 | 8 | 1 | 9 | | 2011 | 8 | 0 | 8 | | 2012 | 7 | 2 | 9 | | 2013 | 15 | 2 | 17 | | 2014 | 14 | 3 | 17 | | 2015 | 19 | 3 | 22 | | 2016 | 13 | 4 | 17 | | 2017 | 11 | 1 | 12 | | 2018 | 11 | 2 | 13 | | 2019 | 11 | 0 | 11 | | 2020 | 12 | 0 | 12 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Ajinkya S, Fox J, Houston P, Greenblatt A, Lekoubou A, Lindhorst S, Cachia D, Olar A, Kutluay E. Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG. J Clin Neurophysiol. 2021 Mar 01; 38(2):143-148.
-
Wang JL, Barth RF, Cavaliere R, Puduvalli VK, Giglio P, Lonser RR, Elder JB. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. PLoS One. 2020; 15(12):e0244383.
-
Cloughesy TF, Petrecca K, Walbert T, Butowski N, Salacz M, Perry J, Damek D, Bota D, Bettegowda C, Zhu JJ, Iwamoto F, Placantonakis D, Kim L, Elder B, Kaptain G, Cachia D, Moshel Y, Brem S, Piccioni D, Landolfi J, Chen CC, Gruber H, Rao AR, Hogan D, Accomando W, Ostertag D, Montellano TT, Kheoh T, Kabbinavar F, Vogelbaum MA. Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial. JAMA Oncol. 2020 12 01; 6(12):1939-1946.
-
Alnahhas I, Rayi A, Thomas D, Ong S, Giglio P, Puduvalli V. False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences. Am J Clin Oncol. 2020 11; 43(11):802-805.
-
Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR. A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. Neuro Oncol. 2020 10 14; 22(10):1505-1515.
-
Rahman M, Sawyer WG, Lindhorst S, Deleyrolle LP, Harrison JK, Karachi A, Dastmalchi F, Flores-Toro J, Mitchell DA, Lim M, Gilbert MR, Reardon DA. Adult immuno-oncology: using past failures to inform the future. Neuro Oncol. 2020 09 29; 22(9):1249-1261.
-
Dodgshun AJ, Fukuoka K, Edwards M, Bianchi VJ, Das A, Sexton-Oates A, Larouche V, Vanan MI, Lindhorst S, Yalon M, Mason G, Crooks B, Constantini S, Massimino M, Chiaravalli S, Ramdas J, Mason W, Ashraf S, Farah R, Van Damme A, Opocher E, Hamid SA, Ziegler DS, Samuel D, Cole KA, Tomboc P, Stearns D, Thomas GA, Lossos A, Sullivan M, Hansford JR, Mackay A, Jones C, Jones DTW, Ramaswamy V, Hawkins C, Bouffet E, Tabori U. Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns. Acta Neuropathol. 2020 11; 140(5):765-776.
-
Das A, Alshareef M, Porto GBF, Infinger LK, Vandergrift WA, Lindhorst SM, Varma AK, Patel SJ, Cachia D. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. J Neurol Sci. 2020 Nov 15; 418:117102.
-
Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming JL, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A. Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. J Clin Oncol. 2020 10 10; 38(29):3407-3417.
-
Sudre CH, Panovska-Griffiths J, Sanverdi E, Brandner S, Katsaros VK, Stranjalis G, Pizzini FB, Ghimenton C, Surlan-Popovic K, Avsenik J, Spampinato MV, Nigro M, Chatterjee AR, Attye A, Grand S, Krainik A, Anzalone N, Conte GM, Romeo V, Ugga L, Elefante A, Ciceri EF, Guadagno E, Kapsalaki E, Roettger D, Gonzalez J, Boutelier T, Cardoso MJ, Bisdas S. Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status. BMC Med Inform Decis Mak. 2020 07 06; 20(1):149.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|